Azenta obtains regulatory approval for clinical long-read whole genome sequencing test

Burlington, mass. , oct. 30, 2024 /prnewswire/ -- azenta, inc. (nasdaq: azta) today announced the launch of a long-read whole genome sequencing (wgs) test for clinical applications.

AZTA Ratings Summary

AZTA Quant Ranking